Barbara B Zimmer

US Patent:

20090023181, Jan 22, 2009

Filed:

Apr 1, 2008

Appl. No.:

12/060756

Inventors:

Katherine S. Sei - El Dorado CA, US
Gerard D. Bordash - Elk Grove CA, US
Collette Y. Wehr - El Dorado Hills CA, US
Barbara L. Zimmer - Davis CA, US
Judith A. Johnston - Carmicheal CA, US
Lou Ann Barnett - Sacramento CA, US

Assignee:

SIEMENS HEALTHCARE DIAGNOSTICS INC. - Deerfield IL

International Classification:

C12Q 1/14
C12M 1/34
C12Q 1/04

US Classification:

435 36, 4352884, 435 34

Abstract:

A device and method are provided for determination of erythromycin-induced clindamycin resistance. The device is preferably a test panel containing one or more wells each having a known concentration(s) of erythromycin and known concentration(s) of clindamycin. After inoculation of the wells with a sample and incubation, the wells are analyzed for growth and to determine whether sample contains a microorganism that expresses erythromycin-induced clindamycin resistance.